These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25722483)

  • 1. Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination.
    Remoli ME; Marchi A; Fortuna C; Benedetti E; Minelli G; Fiorentini C; Mel R; Venturi G; Ciufolini MG
    Pathog Dis; 2015 Mar; 73(2):1-3. PubMed ID: 25722483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
    Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
    J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.
    Jarmer J; Zlatkovic J; Tsouchnikas G; Vratskikh O; Strauß J; Aberle JH; Chmelik V; Kundi M; Stiasny K; Heinz FX
    J Virol; 2014 Dec; 88(23):13845-57. PubMed ID: 25253341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immunity in natural infection by tick-borne encephalitis virus.
    Venturi G; Martelli P; Mazzolini E; Fiorentini C; Benedetti E; Todone D; Villalta D; Fortuna C; Marchi A; Minelli G; Ciufolini MG
    J Med Virol; 2009 Apr; 81(4):665-71. PubMed ID: 19235849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of delayed TBE-vaccine booster.
    Askling HH; Vene S; Rombo L; Lindquist L
    Vaccine; 2012 Jan; 30(3):499-502. PubMed ID: 22122857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
    Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
    Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
    Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
    J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Laaber B; Wiedermann U; Kollaritsch H
    Vaccine; 2009 Nov; 27(50):7027-30. PubMed ID: 19786143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics and Extent of Non-Structural Protein 1-Antibody Responses in Tick-Borne Encephalitis Vaccination Breakthroughs and Unvaccinated Patients.
    Stiasny K; Leitner A; Holzmann H; Heinz FX
    Viruses; 2021 May; 13(6):. PubMed ID: 34072119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmed exposure to tick-borne encephalitis virus and probable human cases of tick-borne encephalitis in Central/Northern Anatolia, Turkey.
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Sener B; Lederer S; Niedrig M; Hasçelik G; Us D
    Zoonoses Public Health; 2011 May; 58(3):220-7. PubMed ID: 20604912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018-2020: an observational study.
    Zavadska D; Freimane Z; Karelis G; Ermina I; Harper LR; Bender C; Zhang P; Angulo FJ; Erber W; Bormane A; Gutmane E; Litauniece ZA; Tihonovs J; Griskevica A; Madhava H; Jodar L
    Clin Microbiol Infect; 2023 Nov; 29(11):1443-1448. PubMed ID: 37422077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection.
    Aberle JH; Schwaiger J; Aberle SW; Stiasny K; Scheinost O; Kundi M; Chmelik V; Heinz FX
    PLoS One; 2015; 10(10):e0140545. PubMed ID: 26465323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.